FDA Clearance Tracker · P150040-S020
VisuMax; VISUMAX 800
Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2025
Approved
Time to decision
178 days
Received Jun 23, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150040-S020
- Device name
- VisuMax; VISUMAX 800
- Applicant
- Carl Zeiss Meditec, Inc.
- Applicant location
- Dublin, CA
- Received
- Jun 23, 2025
- Decided
- Dec 18, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P150040
Device type
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
labeling update that includes the Post-Approval study data from the VisuMax SMILE New Enrollment Study for the VisuMax Femtosecond Laser
Source documents
Other decisions for Carl Zeiss Meditec, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CLARUS (700)510(k)
K243878 · Decided Apr 17, 2025 · 120 days after receipt
Device type: Camera, Ophthalmic, Slit-Scanning (QER) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.